Antoxerene, Inc. reported raising $1.1 Million in an initial SEC Form D filing, from an offering of $1.41 Million
Amount Raised
$1.1 Million
Round Type
Seed
Quick answer
Antoxerene, Inc. raised $1.1 Million in a Seed round, dated June 19, 2017. Antoxerene, Inc. is based in New York, United States.
- How much did Antoxerene, Inc. raise?
- Antoxerene, Inc. raised $1.1 Million in a Seed round on June 19, 2017.
- Where is Antoxerene, Inc. based and how big is it?
- Antoxerene, Inc. is based in New York, United States.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Antoxerene, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Poseida Therapeutics, Inc. raised $11M on August 3, 2017.
- JenaValve raised $9.4M on August 2, 2017.
- Rodeo Therapeutics Corp raised $5.4M on August 2, 2017.
- NeuroOne Medical Technologies Corporation raised an undisclosed amount on August 2, 2017.
- USBC raised $78K (Seed) on August 1, 2017.
- Genix BioMed, Inc. raised an undisclosed amount on August 1, 2017.
Who to call at Antoxerene, Inc., and when
A new round usually means Antoxerene, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Antoxerene, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Antoxerene, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Antoxerene, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Antoxerene, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Antoxerene, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.